Literature DB >> 26135544

Antihyperalgesic effect of duloxetine and amitriptyline in rats after peripheral nerve injury: Influence of descending noradrenergic plasticity.

Hajime Hoshino1, Hideaki Obata2, Shigeru Saito3.   

Abstract

Antidepressants such as serotonin-noradrenaline reuptake inhibitors (SNRIs) and tricyclic antidepressants (TCAs) are frequently used for the management of neuropathic pain. Noradrenaline (NA) and serotonin (5-HT) increase in the spinal cord by reuptake inhibition is considered to be main mechanism of the therapeutic effect of antidepressants in neuropathic pain. In the present study, we examined the analgesic effects of duloxetine (SNRI) and amitriptyline (TCA) in a rat model of neuropathic pain induced by spinal nerve ligation (SNL). Intraperitoneal administration of duloxetine and amitriptyline dose-dependently (3,10 and 30 mg/kg) suppressed hyperalgesia induced by SNL. In vivo microdialysis in the lumbar spinal dorsal horn revealed that NA and 5-HT concentrations increased after intraperitoneal administration of duloxetine and amitriptyline (10 mg/kg, respectively). We further determined NA and 5-HT contents in homogenized samples from the ipsilateral dorsal spinal cord after SNL. Although the NA content in SNL rats 2 weeks after ligation was higher than that in SNL rats 4 weeks after ligation, the analgesic efficacy of duloxetine and amitriptyline was similar between two groups. The present study suggests that NA/5-HT increase in the spinal cord is crucial in the antihyperalgesic effect of duloxetine and amitriptyline. The plastic change of the descending noradrenergic system does not obviously affect the analgesic efficacy of duloxetine and amitriptyline.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Amitriptyline; Antidepressants; Duloxetine; Neuropathic pain; Noradrenaline; Serotonin; Spinal cord

Mesh:

Substances:

Year:  2015        PMID: 26135544     DOI: 10.1016/j.neulet.2015.06.041

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Spinal α2 -adrenoceptors and neuropathic pain modulation; therapeutic target.

Authors:  Zahra Bahari; Gholam Hossein Meftahi
Journal:  Br J Pharmacol       Date:  2019-03-06       Impact factor: 8.739

Review 2.  What do monoamines do in pain modulation?

Authors:  Kirsty Bannister; Anthony H Dickenson
Journal:  Curr Opin Support Palliat Care       Date:  2016-06       Impact factor: 2.302

3.  Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson's Disease.

Authors:  Lei-Fang Cao; Xiao-Yan Peng; Ya Huang; Bing Wang; Feng-Ming Zhou; Ruo-Xiao Cheng; Li-Hua Chen; Wei-Feng Luo; Tong Liu
Journal:  Neural Plast       Date:  2016-09-26       Impact factor: 3.599

4.  Duloxetine Inhibits Microglial P2X4 Receptor Function and Alleviates Neuropathic Pain after Peripheral Nerve Injury.

Authors:  Tomohiro Yamashita; Shota Yamamoto; Jiaming Zhang; Miho Kometani; Daisuke Tomiyama; Keita Kohno; Hidetoshi Tozaki-Saitoh; Kazuhide Inoue; Makoto Tsuda
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

5.  Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies.

Authors:  Hiroyuki Enomoto; Shinji Fujikoshi; Jumpei Funai; Nao Sasaki; Michael H Ossipov; Toshinaga Tsuji; Levent Alev; Takahiro Ushida
Journal:  J Pain Res       Date:  2017-06-01       Impact factor: 3.133

6.  Antihyperalgesic Activity of Atomoxetine on Diabetes-Induced Neuropathic Pain: Contribution of Noradrenergic and Dopaminergic Systems.

Authors:  Mustafa Burak Barbaros; Özgür Devrim Can; Umut İrfan Üçel; Nazlı Turan Yücel; Ümide Demir Özkay
Journal:  Molecules       Date:  2018-08-19       Impact factor: 4.411

Review 7.  Rescue of Noradrenergic System as a Novel Pharmacological Strategy in the Treatment of Chronic Pain: Focus on Microglia Activation.

Authors:  Filippo Caraci; Sara Merlo; Filippo Drago; Giuseppe Caruso; Carmela Parenti; Maria Angela Sortino
Journal:  Front Pharmacol       Date:  2019-09-12       Impact factor: 5.810

8.  Reduction in anxiety during treatment with exercise and duloxetine is related to improvement of low back pain-related disability in patients with non-specific chronic low back pain.

Authors:  Akira Onda; Masashi Kimura
Journal:  Fukushima J Med Sci       Date:  2020

9.  A systematic review on descending serotonergic projections and modulation of spinal nociception in chronic neuropathic pain and after spinal cord stimulation.

Authors:  Lonne Heijmans; Martijn R Mons; Elbert A Joosten
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

10.  Pain condition and sex differences in the descending noradrenergic system following lateral hypothalamic stimulation.

Authors:  Younhee Jeong; Monica A Wagner; Robert J Ploutz-Snyder; Janean E Holden
Journal:  IBRO Rep       Date:  2019-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.